SCHEMBL2272602

SCHEMBL2272602

Cc1ccc(C)c(NC(=O)Nc2cccc(C=O)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 2/20 0.55
MAPT P10636 7/20 0.53
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 3/20 0.50
LMNA P02545 1/20 0.50
ATM Q13315 1/20 0.50
PKM P14618 1/20 0.49
HTT P42858 1/20 0.49
TP53 P04637 1/20 0.48
SAE1 Q9UBE0 1/20 0.48
UBA2 Q9UBT2 1/20 0.48
CXCR2 P25025 1/20 0.48
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2266484 0.86 DDX3X (0.75) DDX3XMAPTMEN1KMT2ANPC1
SCHEMBL2270208 0.86 SAE1 (0.63) MAPTMEN1KMT2ACASP3SENP7
SCHEMBL2268197 0.85 MAPT (0.77) MAPTMEN1KMT2ACASP3SENP7
SCHEMBL2269748 0.84 RAB9A (0.63) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL2268499 0.83 RAB9A (0.56) DDX3XMAPTMEN1KMT2ANPC1
SCHEMBL15866574 0.81 CXCR2 (0.69) DDX3XMAPTMEN1KMT2ACASP3
SCHEMBL11648867 0.79 CA12 (0.62) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL15651741 0.78 TP53 (0.61) DDX3XMAPTMEN1KMT2ACASP3
SCHEMBL25306995 0.76 TP53 (0.54) DDX3XMAPTMEN1KMT2ACASP3
SCHEMBL2350726 0.76 KDR (0.49) MAPTMEN1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420824-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI (FR) 2013-04-16 US disclosed
US-8410286-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI-AVENTIS (FR) 2013-04-02 US disclosed
US-20110237801-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2011-09-29 US disclosed
US-20110237641-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2011-09-29 US disclosed
US-7989439-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI-AVENTIS (FR) 2011-08-02 US disclosed
US-20090291984-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237801-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE ADORA3, ADORA2B, CYP4B1 DDX3X 196/4885MAPT 2805/4885MEN1 2480/4885
US-20090291984-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE CYP4B1, ADORA1, CYP1B1 DDX3X 246/4885MAPT 2843/4885MEN1 2340/4885
US-20110237641-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE ADORA3, ADORA2B, CYP4B1 DDX3X 196/4885MAPT 2805/4885MEN1 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.